Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 12, 2004, Pages 4504-4509

  Savage, Howard I ^a,c   Hendrix, Jason W ^a   Peterson, David C ^a   Young, Heather ^a   Wilkinson, Charles P ^a,b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MASKED CROSS SECTIONAL ANALYSIS; METHODOLOGY; OCULAR BLOOD VESSEL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; STUDENT T TEST; TONOMETRY; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; EYE; HUMANS; LIGHT COAGULATION; MIDDLE AGED; PULSATILE FLOW; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX;

EID: 9444265373     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0077     Document Type: Article

References (37)

1. Klein R, Klein BEK. Vision disorders in diabetes. National Diabetes Data Group. Diabetes in America: Diabetes Data Compiled 1984. Bethesda, MD: U.S. Department of Health And Human Services, 1985:XII-1-XII-36. DHHS publication (NIH) 85-1468.
2. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol. 2001;85:261-266.
3. Aeillo IP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
4. Aiello LP, Cahill MT, Cavallerano JD. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy (review). Eye. 2004;18:117-125.
5. Campochiaro PA. C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthahnol Vis Sci. 2004;45:922-931.
6. Park JY, Takahara N, Gabriele A, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000;49:1239-1248.
7. Yokota T, Ma RC, Park JY, et al. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes. 2003;52:838-845.
8. Aeillo LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
9. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Hormone Res. 2000;53: 53-67.
10. Langham ME, Farrell RA, O'Brien V, et al. Blood flow in the human eye. Acta Ophthalmol. 1989;67(suppl 191):9-13.
11. Bursell SE, Clermont AC, Kinsley BT, et al. Retinal blood flow changes in patients with insulin dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37:886-897.
12. Feke GT, Tagawa H, Yoshida A, et al. Retinal circulatory changes related to retinopathy progression in insulin dependent diabetes mellitus. Ophthalmology. 1985;92:1517-1522.
13. Geyer O, Neudorfer M, Snir T, et al. Pulsatile ocular blood flow in diabetic retinopathy. Acta Ophthalmol. 1999;77:522-525.
14. Grunwald JE, DuPont J, Riva C. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol. 1996;80:327-331.
15. Kohner EM, Hamilton AM, Saunders SJ, Sutcliffe BA, Bulpitt CJ. The retinal blood flow in diabetes. Diabetologia. 1975;11:27-33.
16. MacKinnon JR, O'Brien C, Swa K, et al. Pulsatile ocular blood flow in untreated diabetic retinopathy. Acta Ophthalmol. 1997;75:661-664.
17. Findl O, Dallinger S, Rami B, et al. Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes, Br J Ophthalmol. 2000;84:493-498.
18. Silver DM, Farrell RA, Langham ME, et al. Estimation of pulsatile ocular blood flow from intraocular pressure. Acta Ophthalmol 1989;67(suppl 191):S25-S33.
19. Silver DM, Farrell RA. Validity of pulsatile ocular blood flow measurements. Surv Ophthalmol. 1994;38(suppl):S72-S80.
20. Spraul CW, Lang GE, Ronzani M, et al. Reproducibility of measurements with a new slit lamp-mounted ocular blood flow tonograph. Graefes Arch Clin Exp Ophthalmol. 1998;236:274-279.
21. Schmetterer L, Dallinger S, Findl O, et al. Noninvasive investigations of the normal ocular circulation in humans. Invest Ophthalmol Vis Sci. 1998;39:1210-1220.
22. Shiodte SN, Scherfig E, Nissen OI. A pressure pulse amplitude lowering effect of retinal xenon photocoagulation in normotensive diabetic eyes. Acta Ophthalmol. 1981;59:170-178.
23. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991; 98(suppl 5):823-833.
24. Schmidt KG, Ruckman AV, Kemkes-Matthes B, et al. Ocular pulse amplitude in diabetes mellitus. Br J Ophthalmol, 2000;84:1282-1284.
25. Langham ME, Grebe R, Hopkins S. Choroidal blood flow in diabetic retinopathy. Exp Eye Res. 1991;52:167-173.
26. Patel V, Rassam S, Newsom R. Retinal blood flow in diabetic retinopathy. BMJ. 1992;305:678-683.
27. Trew DR, Smith SE. Postural studies in pulsatile ocular blood flow: ocular hypertension and normotension. Br J Ophthalmol. 1991; 75:66-70.
28. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 1997;64:505-517.
29. Grunwald JE, Riva CE, Brucker AJ, et al. Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy. Ophthalmology. 1986;93:590-595.
30. Mendivil A, Cuartero V. Ocular blood flow velocities in patients with proliferative diabetic retinopathy after scatter photocoagulation: two years of follow up. Retina. 1996;16:222-227.
31. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116:150-154.
32. Mori F, Konno S, Hikichi T, Yamaguchi Y, Ishiko S, Yoshida A. Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration. Br J Ophthalmol. 2001;85:531-533.
33. Chen SJ, Cheng CY, Lee AF, et al. Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration. Br J Ophthalmol. 2001;85:1411-1415.
34. Grunwald JE, Hariprasad SM, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39:385-390.
35. Ciulla TA, Harris A, Kagemann L, et al. Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br J Ophthalmol. 2002;;86:209-213.
36. Uretmen O, Akkin C, Erakgun T, Killi R. Color Doppler imaging of choroidal circulation in patients with asymmetric age-related macular degeneration. Ophthalmologica. 2003;217:137-142.
37. Konno S, Feke GT, Yoshida A, et al. Retinal blood flow changes in type I diabetes. Invest Ophthalmol Vis Sci. 1996;37:1140-1148.